European Companies Search Engine
EU funding (€149,156): Therapeutic potential of optimized derivatives of an endogenous CXCR4 antagonist for the treatment of cancers and inflammatory diseases Hor1 Sept 2018 EU Research and Innovation programme "Horizon"
Overview
Text
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG e. V. - EU funding (€149,156): Therapeutic potential of optimized derivatives of an endogenous CXCR4 antagonist for the treatment of cancers and inflammatory diseases"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.